U.S. markets closed

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
77.68-5.73 (-6.87%)
At close: 04:00PM EST
77.68 0.00 (0.00%)
After hours: 06:03PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close83.41
Bid77.80 x 800
Ask81.65 x 1000
Day's Range77.20 - 83.79
52 Week Range63.69 - 127.42
Avg. Volume454,323
Market Cap3.9B
Beta (5Y Monthly)N/A
PE Ratio (TTM)273.52
EPS (TTM)0.28
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est121.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
6% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NARI

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Inari Medical, Inc.
    PGNY: Lowering target price to $59.00PROGYNY INC has an Investment Rating of BUY; a target price of $59.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • Insider Monkey

    10 Best Growth Stocks for 2022

    In this article, we discuss the 10 best growth stocks for 2022. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Growth Stocks for 2022. The optimism surrounding the global economic recovery has been dented by supply chain concerns and rising inflation. Ratings agency Moody’s estimates that […]

  • Motley Fool

    3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now

    Stock market investing is easier than ever, even if you don't have heaps of cash lying around in your brokerage account. Carefully monitoring organ transplant recipients for initial signs of rejection can save healthcare plan sponsors a bundle. Until CareDx (NASDAQ: CDNA) came along, though, deciding how heavily to compromise a patient's immune system involved a lot of guesswork.

  • Zacks

    Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates

    Inari Medical's (NARI) third-quarter results benefit from new product launches and continued U.S. commercial expansion.